These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16870177)
1. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. Ortt K; Sinha S FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177 [TBL] [Abstract][Full Text] [Related]
2. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Perez CA; Ott J; Mays DJ; Pietenpol JA Oncogene; 2007 Nov; 26(52):7363-70. PubMed ID: 17563751 [TBL] [Abstract][Full Text] [Related]
3. Differential recognition of response elements determines target gene specificity for p53 and p63. Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020 [TBL] [Abstract][Full Text] [Related]
4. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034 [TBL] [Abstract][Full Text] [Related]
5. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters. Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233 [TBL] [Abstract][Full Text] [Related]
6. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359 [TBL] [Abstract][Full Text] [Related]
7. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach. Birkaya B; Ortt K; Sinha S BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas. Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996 [TBL] [Abstract][Full Text] [Related]
11. A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63. Cai BH; Chao CF; Lu MH; Lin HC; Chen JY J Biochem; 2012 Jul; 152(1):99-110. PubMed ID: 22577164 [TBL] [Abstract][Full Text] [Related]
12. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Kim E; Albrechtsen N; Deppert W Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973 [TBL] [Abstract][Full Text] [Related]
13. Definition of a consensus binding site for p53. el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998 [TBL] [Abstract][Full Text] [Related]
14. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation. Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746 [TBL] [Abstract][Full Text] [Related]
15. Identification of vitamin D receptor as a target of p63. Kommagani R; Caserta TM; Kadakia MP Oncogene; 2006 Jun; 25(26):3745-51. PubMed ID: 16462763 [TBL] [Abstract][Full Text] [Related]
16. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262 [TBL] [Abstract][Full Text] [Related]
17. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Schavolt KL; Pietenpol JA Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570 [TBL] [Abstract][Full Text] [Related]
18. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms. Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751 [TBL] [Abstract][Full Text] [Related]
19. p63: Molecular complexity in development and cancer. Westfall MD; Pietenpol JA Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel AP-2 consensus DNA binding site. Gee MS; Sarkisian CJ; el-Deiry WS Biochem Biophys Res Commun; 1998 Feb; 243(1):307-16. PubMed ID: 9473523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]